P. Joly

20.8k total citations · 1 hit paper
295 papers, 9.2k citations indexed

About

P. Joly is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, P. Joly has authored 295 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Pathology and Forensic Medicine, 98 papers in Rheumatology and 89 papers in Dermatology. Recurrent topics in P. Joly's work include Autoimmune Bullous Skin Diseases (137 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (82 papers) and Urticaria and Related Conditions (75 papers). P. Joly is often cited by papers focused on Autoimmune Bullous Skin Diseases (137 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (82 papers) and Urticaria and Related Conditions (75 papers). P. Joly collaborates with scholars based in France, United States and Germany. P. Joly's co-authors include F. Aubin, C. Paul, D. Jullien, S. Aractingi, Michel Le Maître, B. Cribier, L. Misery, Enno Schmidt, M.‐A. Richard and M. D’Incan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

P. Joly

279 papers receiving 9.0k citations

Hit Papers

Pemphigus 2019 2026 2021 2023 2019 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pemphigus
    2019 291 citations P. Joly et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
P. Joly 4.9k 3.8k 2.9k 2.8k 2.7k 295 9.2k
Neil J. Korman 3.1k 0.6× 2.5k 0.7× 4.0k 1.4× 1.3k 0.5× 5.6k 2.0× 163 9.8k
Victoria P. Werth 3.1k 0.6× 7.1k 1.9× 1.9k 0.7× 1.3k 0.5× 4.4k 1.6× 433 12.3k
Jacob M. van Laar 2.7k 0.5× 2.5k 0.7× 727 0.3× 800 0.3× 2.4k 0.9× 251 7.5k
Roberto Giacomelli 2.4k 0.5× 2.5k 0.7× 955 0.3× 649 0.2× 3.1k 1.1× 304 9.3k
Peter Nash 1.7k 0.4× 7.4k 2.0× 1.0k 0.4× 1.0k 0.4× 5.2k 1.9× 344 11.5k
Michael Sticherling 1.4k 0.3× 1.8k 0.5× 1.0k 0.4× 825 0.3× 2.3k 0.8× 214 5.9k
Russell P. Hall 1.8k 0.4× 1.3k 0.4× 775 0.3× 1.0k 0.4× 1.4k 0.5× 119 5.1k
Armando Gabrielli 2.9k 0.6× 1.3k 0.3× 1.1k 0.4× 458 0.2× 1.7k 0.6× 174 6.5k
M. Bagot 2.7k 0.6× 1.6k 0.4× 4.0k 1.4× 284 0.1× 2.5k 0.9× 365 8.2k
Frank A. Wollheim 4.1k 0.8× 1.9k 0.5× 1.4k 0.5× 224 0.1× 1.6k 0.6× 125 7.2k

Countries citing papers authored by P. Joly

Since Specialization
Citations

This map shows the geographic impact of P. Joly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Joly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Joly more than expected).

Fields of papers citing papers by P. Joly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Joly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Joly. The network helps show where P. Joly may publish in the future.

Co-authorship network of co-authors of P. Joly

This figure shows the co-authorship network connecting the top 25 collaborators of P. Joly. A scholar is included among the top collaborators of P. Joly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Joly. P. Joly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tedbirt, Billal, Maria C. Bolling, Joost M. Meijer, et al.. (2025). Outcome measurement in pemphigus clinical research: a scoping review on heterogeneity in outcome reporting and definitions. British Journal of Dermatology. 193(2). 221–231.
2.
King, Brett, Jennifer Soung, Christos Tziotzios, et al.. (2024). Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program. American Journal of Clinical Dermatology. 25(2). 299–314. 27 indexed citations
3.
Werth, Victoria P., et al.. (2024). Bullous pemphigoid burden of disease, management and unmet therapeutic needs. Journal of the European Academy of Dermatology and Venereology. 39(2). 290–300. 2 indexed citations
4.
Tancrède‐Bohin, Emmanuelle, M. Alexandre, S. Oro, et al.. (2023). Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study. Journal of the American Academy of Dermatology. 90(1). 204–208. 2 indexed citations
5.
Soung, Jennifer, Brett King, Christos Tziotzios, et al.. (2023). 43117 Integrated safety analysis of ritlecitinib in adolescent patients with alopecia areata from the randomized, placebo-controlled ALLEGRO phase 2b/3 and ongoing open-label phase 3 ALLEGRO-LT studies. Journal of the American Academy of Dermatology. 89(3). AB182–AB182. 1 indexed citations
6.
Tedbirt, Billal, P. Joly, & André Gillibert. (2023). Individual meta‐analysis of vital prognostic factors of patients with bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. 37(7). e917–e919. 1 indexed citations
7.
Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2023). Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort. Annales de Dermatologie et de Vénéréologie. 150(2). 101–108. 1 indexed citations
8.
9.
Taïeb, C., P. Joly, J.‐F. Séi, et al.. (2022). Patient Perception of the Diagnosis Announcement and its Impact on Quality of Life of Patients with Primary Melanoma or Basal Cell Carcinoma. Acta Dermato Venereologica. 102. adv00717–adv00717. 3 indexed citations
10.
Mahé, E., M.‐A. Richard, Yann De Rycke, et al.. (2021). Impact de l’épidémie de COVID-19 lors de la 1ère vague sur les patients de la cohorte PSOBIOTEQ traités pour psoriasis cutané. PubMed Central. 1(8). A298–A299. 1 indexed citations
11.
Drenovska, Kossara, Snejina Vassileva, Ivan Tanev, & P. Joly. (2021). Impact of COVID-19 on autoimmune blistering diseases. Clinics in Dermatology. 39(3). 359–368. 12 indexed citations
12.
Tedbirt, Billal, et al.. (2020). Reactive Eccrine Syringofibroadenomatosis Associated With Venous Leg Ulcers: A Case Report and Literature Review. The International Journal of Lower Extremity Wounds. 22(1). 135–138.
13.
Gillibert, André, S. Duvert‐Lehembre, M. Alexandre, et al.. (2020). Sensitivity to change and correlation between the autoimmune bullous disease quality‐of‐life questionnaires ABQOL and TABQOL , and objective severity scores. British Journal of Dermatology. 183(5). 944–945. 8 indexed citations
14.
Tedbirt, Billal, Sydney Dubois, Aspasia Stamatoullas, et al.. (2020). Multiple cutaneous ulcers revealing a primary cutaneous Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma. SHILAP Revista de lepidopterología. 8(12). 2578–2582. 3 indexed citations
15.
Brenaut, E., C. Horreau, Claire Pouplard, et al.. (2013). Alcohol consumption and psoriasis: a systematic literature review. Journal of the European Academy of Dermatology and Venereology. 27(s3). 30–35. 118 indexed citations
16.
Roux‐Villet, C. Le, et al.. (2010). Rôle infirmier dans la prise en charge de la pemphigoïde bulleuse. La Revue de l Infirmière. 38–40. 2 indexed citations
17.
Danaila, Ionut, P. Joly, & Sidi Mahmoud Kaber. (2005). Introduction au calcul scientifique par la pratique : 12 projets résolus avec Matlab. Dunod eBooks. 1 indexed citations
18.
Sergent, F., et al.. (2002). [Pregnancy: a possible etiology of pyoderma gangrenosum. A case report and review of the literature].. PubMed. 31(5). 506–11. 8 indexed citations
19.
Joly, P., et al.. (1998). Flow Cytometry Analysis of Peripheral Blood Lymphocytes from Patients with Bullous Pemphigoid. Dermatology. 197(2). 137–140. 3 indexed citations
20.
Joly, P., et al.. (1993). [Metastatic basal cell carcinoma].. PubMed. 120(2). 135–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil J. Korman Breakdown of academic impact, for papers by Victoria P. Werth Breakdown of academic impact, for papers by Jacob M. van Laar Breakdown of academic impact, for papers by Roberto Giacomelli Breakdown of academic impact, for papers by Peter Nash Breakdown of academic impact, for papers by Michael Sticherling Breakdown of academic impact, for papers by Russell P. Hall Breakdown of academic impact, for papers by Armando Gabrielli Breakdown of academic impact, for papers by M. Bagot Breakdown of academic impact, for papers by Frank A. Wollheim
Rankless by CCL
2026